LSDBs and How They Have Evolved

Human Mutation

Volumn 37, Issue 6, 2016, Pages 532-539

  Dalgleish, Raymond ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Data quality assurance; Database; LSDB; Mutation; Reference sequence; Sequence variant; Software; Variant nomenclature

Indexed keywords

GENE LOCUS; GENE MUTATION; GENETIC DATABASE; GENETIC VARIATION; HEMOGLOBINOPATHY; HUGO GENE NOMENCLATURE; HUMAN; LOCUS SPECIFIC DATABASE; PRIORITY JOURNAL; REVIEW; SEQUENCE ANALYSIS; BIOLOGY; GENETIC PREDISPOSITION; STANDARDS; WEB BROWSER;

COMPUTATIONAL BIOLOGY; DATABASES, GENETIC; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; WEB BROWSER;

EID: 84960856316     PISSN: 10597794     EISSN: 10981004     Source Type: Journal    
DOI: 10.1002/humu.22979     Document Type: Review

References (92)

1. Amberger JS, Bocchini CA, Schiettecatte F, Scott AF, Hamosh A. 2015. OMIM.org: Online Mendelian Inheritance in Man (OMIM®), an online catalog of human genes and genetic disorders. Nucleic Acids Res 43:D789-D798.
2. Auerbach AD, Burn J, Cassiman JJ, Claustres M, Cotton RGH, Cutting G, den Dunnen JT, El-Ruby M, Vargas AF, Greenblatt MS, Macrae F, Matsubara Y, et al. 2011. Mutation (variation) databases and registries: a rationale for coordination of efforts. Nat Rev Genet 12:2.
3. Ayme S, Terry SF, Groft S. 2011. Response to 'Mutation (variation) databases and registries: a rationale for coordination of efforts': an IRDiRC perspective. Nat Rev Genet 12:1.
4. Beaudet AL, Tsui LC. 1993. A suggested nomenclature for designating mutations. Hum Mutat 2:245-248.
5. Benson D, Lipman DJ, Ostell J. 1993. GenBank. Nucleic Acids Res 21:2963-2965.
6. Béroud C, Hamroun D, Collod-Béroud G, Boileau C, Soussi T, Claustres M. 2005. UMD (Universal Mutation Database): 2005 update. Hum Mutat 26:184-191.
7. Berwouts S, Morris MA, Girodon E, Schwarz M, Stuhrmann M, Dequeker E. 2011. Mutation nomenclature in practice: findings and recommendations from the cystic fibrosis external quality assessment scheme. Hum Mutat 32:1197-1203.
8. Beutler E. 1993. The designation of mutations. Am J Hum Genet 53:783-785.
9. Beutler E, McKusick VA, Motulsky AG, Scriver CR, Hutchinson F. 1996. Mutation nomenclature: nicknames, systematic names, and unique identifiers. Hum Mutat 8:203-206.
10. Bhattacharya A, Cui Y. 2016. SomamiR 2.0: a database of cancer somatic mutations altering microRNA-ceRNA interactions. Nucleic Acids Res 44:D1005-D1010.
11. Brookes AJ, Robinson PN. 2015. Human genotype-phenotype databases: aims, challenges and opportunities. Nat Rev Genet 16:702-715.
12. Brown AF, McKie MA. 2000. MuStaR and other software for locus-specific mutation databases. Hum Mutat 15:76-85.
13. Bunn HF, Forget BG, Ranney HM. 1977a. Human Hemoglobins. Philadelphia: WB Saunders Company. 432 p.
14. Bunn HF, G. FB, Ranney HM. 1977b. Hemoglobinopathies. Philadelphia: WB Saunders Company. 308 p.
15. Castellani C. 2013. CFTR2: How will it help care? Paediatr Respir Rev 14 Suppl 1:2-5.
16. Celli J, Dalgleish R, Vihinen M, Taschner PEM, den Dunnen JT. 2012. Curating gene variant databases (LSDBs): toward a universal standard. Hum Mutat 33:291-297.
17. Claustres M, Horaitis O, Vanevski M, Cotton RGH. 2002. Time for a unified system of mutation description and reporting: A review of locus-specific mutation databases. Genome Res 12:680-688.
18. Cotton RGH, Horaitis O. 2002. The HUGO Mutation Database Initiative. Pharmacogenomics J 2:16-19.
19. Cotton RGH, Phillips K, Horaitis O. 2007. A survey of locus-specific database curation. Human Genome Variation Society. J Med Genet 44:e72.
20. Cotton RGH, Sallée C, Knoppers BM. 2005. Locus-specific databases: from ethical principles to practice. Hum Mutat 26:489-493.
21. Cotton RGH, Scriver CR. 1998. Proof of "disease causing" mutation. Hum Mutat 12:1-3.
22. Cotton RGH, Scriver CR, McKusick VA. 1996. Locus-specific mutation databases: a resource. Genome Digest January:6-10.
23. Cruts M, Theuns J, Van Broeckhoven C. 2012. Locus-specific mutation databases for neurodegenerative brain diseases. Hum Mutat 33:1340-1344.
24. Dalgleish R. 1997. The human type I collagen mutation database. Nucleic Acids Res 25:181-187.
25. Dalgleish R. 1998. The human collagen mutation database 1998. Nucleic Acids Res 26:253-255.
26. Dalgleish R. 2011. Boning up on mutations: assessing the significance of candidate disease-causing DNA sequence variation. Genet Mol Res 10:1518-1521.
27. Dalgleish R, Flicek P, Cunningham F, Astashyn A, Tully RE, Proctor G, Chen Y, McLaren WM, Larsson P, Vaughan BW, Béroud C, Dobson G, et al. 2010. Locus Reference Genomic sequences: an improved basis for describing human DNA variants. Genome Med 2:24.
28. den Dunnen JT, Antonarakis SE. 2000. Mutation nomenclature extensions and suggestions to describe complex mutations: A discussion. Hum Mutat 15:7-12.
29. den Dunnen JT, Dalgleish R, Maglott DR, Hart RK, Greenblatt MS, McGowan-Jordan J, Roux A-F, Smith T, Antonarakis SE, Taschner PEM on behalf of the Human Genome Variation Society (HGVS), the Human Variome Project (HVP), and the Human Genome Organisation (HUGO). 2016. HGVS recommendations for the description of sequence variants: 2016 update. Hum Mutat 37:564-569.
30. Emmert DB, Stoehr PJ, Stoesser G, Cameron GN. 1994. The European Bioinformatics Institute (EBI) databases. Nucleic Acids Res 22:3445-3449.
31. Fokkema IFAC, Taschner PEM, Schaafsma GCP, Celli J, Laros JFJ, den Dunnen JT. 2011. LOVD v.2.0: The next generation in gene variant databases. Hum Mutat 32:557-563.
32. Gazzo AM, Daneels D, Cilia E, Bonduelle M, Abramowicz M, Van Dooren S, Smits G, Lenaerts T. 2016. DIDA: A curated and annotated digenic diseases database. Nucleic Acids Res 44:D900-D907.
33. Gbadegesin RA, Brophy PD, Adeyemo A, Hall G, Gupta IR, Hains D, Bartkowiak B, Rabinovich CE, Chandrasekharappa S, Homstad A, Westreich K, Wu G, et al. 2013. TNXB mutations can cause vesicoureteral reflux. J Am Soc Nephrol 24:1313-1322.
34. George RA, Smith TD, Callaghan S, Hardman L, Pierides C, Horaitis O, Wouters MA, Cotton RGH. 2008a. General mutation databases: analysis and review. J Med Genet 45:65-70.
35. George RA, Smith TD, Callaghan S, Hardman L, Pierides C, Horaitis O, Wouters MA, Cotton RGH. 2008b. Response to Stenson et al on the review of general mutation databases. J Med Genet 45:319-320.
36. Giardine B, Borg J, Viennas E, Pavlidis C, Moradkhani K, Joly P, Bartsakoulia M, Riemer C, Miller W, Tzimas G, Wajcman H, Hardison RC, et al. 2014. Updates of the HbVar database of human hemoglobin variants and thalassemia mutations. Nucleic Acids Res 42:D1063-D1069.
37. Giardine B, van Baal S, Kaimakis P, Riemer C, Miller W, Samara M, Kollia P, Anagnou NP, Chui DH, Wajcman H, Hardison RC, Patrinos GP. 2007. HbVar database of human hemoglobin variants and thalassemia mutations: 2007 update. Hum Mutat 28:206.
38. Giglione C, Boularot A, Meinnel T. 2004. Protein N-terminal methionine excision. Cell Mol Life Sci 61:1455-1474.
39. Graeber SY, Hug MJ, Sommerburg O, Hirtz S, Hentschel J, Heinzmann A, Dopfer C, Schulz A, Mainz JG, Tümmler B, Mall MA. 2015. Intestinal current measurements detect activation of mutant CFTR in patients with cystic fibrosis with the G551D mutation treated with Ivacaftor. Am J Respir Crit Care Med 192:1252-1255.
40. Hardison RC, Chui DHK, Giardine B, Riemer C, Patrinos GP, Anagnou N, Miller W, Wajcman H. 2002. HbVar: A relational database of human hemoglobin variants and thalassemia mutations at the globin gene server. Hum Mutat 19:225-233.
41. Hardison RC, Chui DHK, Riemer CR, Miller W, Carver MFH, Molchanova TP, Efremov GD, Huisman THJ. 1998. Access to a syllabus of human hemoglobin variants (1996) via the World Wide Web. Hemoglobin 22:113-127.
42. Hart RK, Rico R, Hare E, Garcia J, Westbrook J, Fusaro VA. 2015. A Python package for parsing, validating, mapping and formatting sequence variants using HGVS nomenclature. Bioinformatics 31:268-270.
43. Harte RA, Farrell CM, Loveland JE, Suner M-M, Wilming L, Aken B, Barrell D, Frankish A, Wallin C, Searle S, Diekhans M, Harrow J, et al. 2012. Tracking andbrk coordinating an international curation effort for the CCDS Project. Database (Oxford) 2012:bas008.
44. Herrick JB. 1910. Peculiar elongated and sickle-shaped red blood corpuscles in a case of severe anemia. Arch Intern Med 6:517-521.
45. Horaitis O, Cotton RGH. 2004. The challenge of documenting mutation across the genome: the Human Genome Variation Society approach. Hum Mutat 23:447-452.
46. Huisman THJ, Carver MFH, Baysal E. 1997. A Syllabus of Thalassemia Mutations. Augusta, Georgia: Sickle Cell Anemia Foundation. 309 p.
47. Huisman THJ, Carver MFH, Efremov GD. 1996. A Syllabus of Human Hemoglobin Variants. Augusta, Georgia: The Sickle Cell Anemia Foundation.
48. Huisman THJ, Carver MFH, Efremov GD. 1998. A syllabus of Human Hemoglobin Variants.2nd ed. Augusta, Georgia: The Sickle Cell Anemia Foundation.
49. Ingram VM. 1956. A specific chemical difference between the globins of normal human and sickle-cell anaemia haemoglobin. Nature 178:792-794.
50. Ingram VM. 1957. Gene mutations in human haemoglobin: the chemical difference between normal and sickle cell haemoglobin. Nature 180:326-328.
51. Johnston JJ, Biesecker LG. 2013. Databases of genomic variation and phenotypes: existing resources and future needs. Hum Mol Genet 22:R27-R31.
52. Kountouris P, Lederer CW, Fanis P, Feleki X, Old J, Kleanthous M. 2014. IthaGenes: an interactive database for haemoglobin variations and epidemiology. PloS One 9:e103020.
53. Landrum MJ, Lee JM, Benson M, Brown G, Chao C, Chitipiralla S, Gu B, Hart J, Hoffman D, Hoover J, Jang W, Katz K, et al. 2016. ClinVar: public archive of interpretations of clinically relevant variants. Nucleic Acids Res 44:D862-868.
54. Lehmann H, Kynoch PAM. 1976. Human haemoglobin variants and their characteristics. Amsterdam: North-Holland Publishing Company. 241 p.
55. Livingstone FB. 1967. Abnormal hemoglobins in human populations. Chicago: Aldine Publishing Company. 476 p.
56. MacArthur JAL, Morales J, Tully RE, Astashyn A, Gil L, Bruford EA, Larsson P, Flicek P, Dalgleish R, Maglott DR, Cunningham F. 2014. Locus Reference Genomic: reference sequences for the reporting of clinically relevant sequence variants. Nucleic Acids Res 42:D873-D878.
57. Macchiato MF, Tramontano A. 1990. VARIANT: a store and retrieval system for human haemoglobin variants. Comput Methods Programs Biomed 31:113-114.
58. Marotta CA, Forget BG, Weissman SM, Verma IM, McCaffrey RP, Baltimore D. 1974. Nucleotide sequences of human globin messenger RNA. Proc Natl Acad Sci USA 71:2300-2304.
59. Mitropoulou C, Webb AJ, Mitropoulos K, Brookes AJ, Patrinos GP. 2010. Locus-specific database domain and data content analysis: evolution and content maturation toward clinical use. Hum Mutat 31:1109-1116.
60. Niroula A, Vihinen M. 2016. Variation interpretation predictors: principles, types, performance and choice. Hum Mutat 37:579-597.
61. O'Leary NA, Wright MW, Brister JR, Ciufo S, Haddad D, McVeigh R, Rajput B, Robbertse B, Smith-White B, Ako-Adjei D, Astashyn A, Badretdin A, et al. 2016. Reference sequence (RefSeq) database at NCBI: current status, taxonomic expansion, and functional annotation. Nucleic Acids Res 44:D733-D745.
62. Ogino S, Gulley ML, den Dunnen JT, Wilson RB. 2007. Standard mutation nomenclature in molecular diagnostics: practical and educational challenges. J Mol Diagn 9:1-6.
63. Patnaik SK, Helmberg W, Blumenfeld OO. 2012. BGMUT: NCBI dbRBC database of allelic variations of genes encoding antigens of blood group systems. Nucleic Acids Res 40:D1023-1029.
64. Patrinos GP, Giardine B, Riemer C, Miller W, Chui DH, Anagnou NP, Wajcman H, Hardison RC. 2004. Improvements in the HbVar database of human hemoglobin variants and thalassemia mutations for population and sequence variation studies. Nucleic Acids Res 32:D537-D541.
65. Pauling L, Itano HA, Singer SJ, Wells IC. 1949. Sickle cell anemia, a molecular disease. Science 110:543-548.
66. Pesci E, Bettinetti L, Fanti P, Galietta LJV, La Rosa S, Magnoni L, Pedemonte N, Sardone GL, Maccari L. 2015. Novel hits in the correction of ΔF508-cystic fibrosis transmembrane conductance regulator (CFTR) protein: synthesis, pharmacological, and ADME evaluation of tetrahydropyrido[4, 3-d]pyrimidines for the potential treatment of cystic fibrosis. J Med Chem.
67. Povey S, Al Aqeel AI, Cambon-Thomsen A, Dalgleish R, den Dunnen JT, Firth HV, Greenblatt MS, Barash CI, Parker M, Patrinos GP, Savige J, Sobrido M-J, et al. 2010. Practical guidelines addressing ethical issues pertaining to the curation of human locus-specific variation databases (LSDBs). Hum Mutat 31:1179-1184.
68. Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, Grody WW, Hegde M, Lyon E, Spector E, Voelkerding K, Rehm HL. 2015. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 17:405-424.
69. Riikonen P, Vihinen M. 1999. MUTbase: maintenance and analysis of distributed mutation databases. Bioinformatics 15:852-859.
70. Ritchie GRS, Flicek P. 2014. Computational approaches to interpreting genomic sequence variation. Genome Med 6:87.
71. Rucknagel DL. 1964. Current concepts of the genetics of thalassemia. Ann N Y Acad Sci 119:436-449.
72. Samuels ME, Rouleau GA. 2011. The case for locus-specific databases. Nat Rev Genet 12:378-379.
73. Savige J, Dalgleish R, Cotton RGH, den Dunnen JT, Macrae F, Povey S. 2015. The Human Variome Project: ensuring the quality of DNA variant databases in inherited renal disease. Pediatr Nephrol 30:1893-1901.
74. Schäffer AA. 2013. Digenic inheritance in medical genetics. J Med Genet 50:641-652.
75. Shaffer LG, McGowan-Jordan J, Schmid M. 2013. ISCN (2013): an international system for human cytogenetic nomenclature. Basel: S. Karger.
76. Soussi T. 2014. Locus-specific databases in cancer: what future in a post-genomic era? The TP53 LSDB paradigm. Hum Mutat 35:643-653.
77. Stenson PD, Ball E, Howells K, Phillips A, Mort M, Cooper DN. 2008. Human Gene Mutation Database: towards a comprehensive central mutation database. J Med Genet 45:124-126.
78. Stenson PD, Mort M, Ball EV, Shaw K, Phillips A, Cooper DN. 2014. The Human Gene Mutation Database: building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine. Hum Genet 133:1-9.
79. Swertz MA, Dijkstra M, Adamusiak T, van der Velde JK, Kanterakis A, Roos ET, Lops J, Thorisson GA, Arends D, Byelas G, Muilu J, Brookes AJ, et al. 2010. The MOLGENIS toolkit: rapid prototyping of biosoftware at the push of a button. BMC Bioinformatics 11 Suppl 12:S12.
80. Tack V, Deans ZC, Wolstenhome N, Patton S, Dequeker EMC. 2016. What's in a name? A coordinated approach towards a uniform nomenclature to improve patient reports and databases. Hum Mutat 37:570-575.
81. Taliaferro WH, Huck JG. 1923. The inheritance of sickle-cell anaemia in man. Genetics 8:594-598.
82. Taschner PEM, den Dunnen JT. 2011. Describing structural changes by extending HGVS sequence variation nomenclature. Hum Mutat 32:507-511.
83. Thein SL, Hesketh C, Taylor P, Temperley IJ, Hutchinson RM, Old JM, Wood WG, Clegg JB, Weatherall DJ. 1990. Molecular basis for dominantly inherited inclusion body beta-thalassemia. Proc Natl Acad Sci USA 87:3924-3928.
84. Vail PJ, Morris B, van Kan A, Burdett BC, Moyes K, Theisen A, Kerr ID, Wenstrup RJ, Eggington JM. 2015. Comparison of locus-specific databases for BRCA1 and BRCA2 variants reveals disparity in variant classification within and among databases. J Community Genet 6:351-359.
85. van den Akker PC, Jonkman MF, Rengaw T, Bruckner-Tuderman L, Has C, Bauer JW, Klausegger A, Zambruno G, Castiglia D, Mellerio JE, McGrath JA, van Essen AJ, et al. 2011. The international dystrophic epidermolysis bullosa patient registry: an online database of dystrophic epidermolysis bullosa patients and their COL7A1 mutations. Hum Mutat 32:1100-1107.
86. Vihinen M. 2013. Guidelines for reporting and using prediction tools for genetic variation analysis. Hum Mutat 34:275-282.
87. Vihinen M. 2015. Muddled genetic terms miss and mess the message. Trends Genet 31:423-425.
88. Vihinen M, den Dunnen JT, Dalgleish R, Cotton RGH. 2012. Guidelines for establishing locus specific databases. Hum Mutat 33:298-305.
89. Wildeman M, van Ophuizen E, den Dunnen JT, Taschner PEM. 2008. Improving sequence variant descriptions in mutation databases and literature using the Mutalyzer sequence variation nomenclature checker. Hum Mutat 29:6-13.
90. Zhang F, Lupski JR. 2015. Non-coding genetic variants in human disease. Hum Mol Genet 24:R102-R110.
91. Zhao X, Xiao J, Wang H, Ren X, Gao J, Wu Y, Lu C, Zhang X. 2015. Spectrum of COL1A1/2 mutations and gene diagnosis in Chinese patients with osteogenesis imperfecta. Zhonghua Yi Xue Za Zhi 95:3484-3489.
92. Zhao Y, Yuan J, Chen R. 2016. NONCODEv4: Annotation of noncoding RNAs with emphasis on long noncoding RNAs. Methods Mol Biol 1402:243-254.